Monday, June 3, 2019
- 5:30pm-5:42pm
-
Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab
- 5:30pm-5:42pm
-
Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients
Concurrent Session: Breakthroughs in Cytomegalovirus • Ballroom A
- 5:42pm-5:54pm
-
A Kidney Transplant Recipient with Severe Acute GvHD Promptly Rescued by Donor HLA-Targeted Serotherapy
- 5:42pm-5:54pm
-
AKI and Long-Term Risk for Cardiovascular Events in Patients after Kidney Transplantation
- 5:42pm-5:54pm
-
Gut Dysbiosis Predominates Post-Transplant Diarrhea in Kidney Transplant Recipients: A Validation Study
- 5:42pm-5:54pm
-
Intravenous Immunoglobulin Significantly Reduces Bioavailability of Concomitantly Administered Anti-C5 Monoclonal Antibodies
- «Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 57
- Next Page»